Advertisement
Direxion Daily S&P Biotech Bull 3X ETF

Direxion Daily S&P Biotech Bull 3X ETF (LABU) Stock Competitors & Peer Comparison

See (LABU) competitors and their performances in Stock Market.

LABUAMEX
Financial ServicesAsset Management - Leveraged
$168.00
$8.85(5.56%)
U.S. Market is Open · 11:20
Advertisement

Peer Comparison Table: Asset Management - Leveraged Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
LABU$168.00+5.56%906.6MN/AN/A+0.79%
LACG$6.84-16.47%216.2BN/AN/AN/A
FFEU$90.85+0.48%212.8BN/AN/AN/A
GRAG$5.40-1.50%116.7BN/AN/AN/A
VTAPX$25.24+0.12%70.5BN/AN/A+3.76%
SOXL$192.30-9.05%59.3B43.41$4.64+0.04%
VFSUX$10.37+0.10%55.2B59.64$0.17+4.59%
VFSTX$10.37+0.10%55.2B59.64$0.17+4.48%
VSBSX$19.38+0.10%33.9BN/AN/A+3.94%
TQQQ$71.78-5.89%26.5B37.79$1.95+0.44%
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

LABU vs LACG Comparison June 2026

LABU plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, LABU stands at 906.6M. In comparison, LACG has a market cap of 216.2B. Regarding current trading prices, LABU is priced at $168.00, while LACG trades at $6.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

LABU currently has a P/E ratio of N/A, whereas LACG's P/E ratio is N/A. In terms of profitability, LABU's ROE is +0.00%, compared to LACG's ROE of +0.00%. Regarding short-term risk, LABU is more volatile compared to LACG. This indicates potentially higher risk in terms of short-term price fluctuations for LABU.Check LACG's competition here

Stock price comparison of stocks in the Financial Services Sector

Loading...

Frequently Asked Questions